Deacylketoconazole Inhibitor

Deacylketoconazole is a Ketoconazole derivative. Ketoconazole is an antifungal drug used primarily for the treatment,of fungal infections.

Fukami T, Iida A, Konishi K, Nakajima M. Human arylacetamide deacetylase hydrolyzes ketoconazole to trigger hepatocellular toxicity. Biochem Pharmacol. 2016 Sep 15;116:153-61. doi: 10.1016/j. Bcp.2016.07.007. Epub 2016 Jul 12. PubMed PMID: 27422753.
Wewering F, Jouy F, Wissenbach DK, Gebauer S, Bluher M, Gebhardt R, Pirow R, von Bergen M, Kalkhof S, Luch A, Zellmer S. Characterization of chemical-induced sterile inflammation in vitro: application of the model compound ketoconazole in a human hepatic co-culture system. Arch Toxicol. 2017 Feb;91(2):799-810. doi: 10.1007/s00204-016-1686-y. Epub 2016 Mar 10. PubMed PMID: 26965496.
Rodriguez RJ, Miranda CL. Isoform specificity of N-deacetyl ketoconazole by human and rabbit flavin-containing monooxygenases. Drug Metab Dispos. 2000 Sep;28(9):1083-6. PubMed PMID: 10950853.
Rodriguez RJ, Proteau PJ, Marquez BL, Hetherington CL, Buckholz CJ, O'Connell KL. Flavin-containing monooxygenase-mediated metabolism of N-deacetyl ketoconazole by rat hepatic microsomes. Drug Metab Dispos. 1999 Aug;27(8):880-6. PubMed PMID: 10421614.

Small volumes of Deacylketoconazole, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

MBS5756617 is an inhibitor targeting Deacylketoconazole.